BSD Medical Corporation Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	56
ISBN Number	not applicable
Product Code	GMD04662

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a BSD Medical Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Recent Developments
- 10.1 Financial Announcements
  - 10.1.1 Jul 10, 2008: BSD Medical Reports Q3 Fiscal 2008 Results
  - 10.1.2 Apr 09, 2008: BSD Medical Reports Q2 Fiscal 2008 Results
  - 10.1.3 Jan 10, 2008: BSD Medical Reports Q1 Fiscal 2008 Results
  - 10.1.4 Nov 14, 2007: BSD Medical Declares 2007 Results
  - 10.1.5 Nov 29, 2006: BSD Medical Declares 2006 Results
- 10.2 Corporate Communications
  - 10.2.1 Apr 22, 2008: BSD Medical To Open Trading On NASDAQ
  - 10.2.2 Apr 10, 2008: BSD Medical To Be Listed On The NASDAQ Stock Exchange
  - 10.2.3 May 02, 2007: BSD Medical Appoints CFO
  - 10.2.4 Jul 06, 2006: BSD Medical Joins Russell Microcap Index
  - 10.2.5 Jan 09, 2006: BSD Medical Appoints Board Member
  - 10.2.6 Jun 09, 2005: BSD Medical To Begin Trading On AMEX
- 10.3 Legal and Regulatory
  - 10.3.1 Apr 11, 2007: BSD Medical Says FDA Requires No Further Response On Warning Letter
  - 10.3.2 Mar 07, 2007: BSD Medical Receives FDA Warning Letter
- 10.4 Product News
  - 10.4.1 Jul 31, 2008: BSD Medical's Premier Cancer Treatment System Can Now Treat Children's Cancers
  - 10.4.2 Jul 03, 2008: Seven Major US Cancer Institutions Order Hyperthermia Systems From BSD Medical
  - 10.4.3 Jun 30, 2008: BSD Medical Reports Status On Submissions To FDA : MicroThermX-100 Ablation System
  - 10.4.4 Jun 25, 2008: BSD-2000 Cancer Treatment System By BSD Medical Installed In Prestigious Liaocheng Peoples Hospital In China
  - 10.4.5 Jun 10, 2008: Italy To Receive First BSD-2000/3D Deep Regional Hyperthermia System
  - 10.4.6 May 28, 2008: Phase III Clinical Study Using BSD Medical's Systems For Treating Pancreatic Cancer To Be Announced At ASCO
  - 10.4.7 Apr 15, 2008: BSD Medical Submits 510(k) Premarket Notification for MicroThermX-100 Microwave Ablation System
  - 10.4.8 Dec 04, 2007: BSD-2000 Cancer Treatment System Purchased By Nanchong Hospital In China
  - 10.4.9 Oct 17, 2007: Hyperthermia Combined With Radiation And Androgen Therapy Provides Positive Results With Reduced Toxicity For Prostate Cancer Treatments
  - 10.4.10 Sep 27, 2007: BSD Medical Reports Upcoming Publication Of 12-Year Cancer Survival Data Following Landmark Study Of Hyperthermia Therapy
  - 10.4.11 Sep 18, 2007: BSD Medicals Hyperthermia Therapy Now Offered At Northeast Radiation Oncology Center
  - 10.4.12 Sep 11, 2007: Generous Donation By Dietmar-Hopp Foundation Launches Hyperthermia Therapy Program For Cancer Treatment At Heidelberg University
  - 10.4.13 Aug 23, 2007: BSD Medical Announces Successful Conclusion Of FDA Pre-Approval Audit For BSD-2000 PMA Submission
  - 10.4.14 Aug 14, 2007: BSD Medical Obtains Patent License For Primary Breast Cancer Treatment System From Duke University
  - 10.4.15 Jul 31, 2007: BSD Medical Files Response To FDA Questions On BSD-2000 PMA Submission Following Meeting With FDA
  - 10.4.16 Jun 22, 2007: Twelve-Year Survival Data Shows Durability Of Hyperthermia Therapys Enhancement Of Radiation In Treating Cancer
  - 10.4.17 Jun 11, 2007: BSD-2000 Cancer Treatment System Acquired In Taiyuan City, China
  - 10.4.18 Jun 05, 2007: Major Study Of BSD Medicals Cancer Therapy In Combination With Chemotherapy Highlighted In ASCO News And In Summary Session
  - 10.4.19 Jun 04, 2007: Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared To Chemotherapy Alone For Sarcoma Cancer Patients
  - 10.4.20 Apr 20, 2007: BSD Medical Exhibits The BSD-2000 At Asias Largest Medical Device Exposition
  - 10.4.21 Apr 11, 2007: FDA Requires No Further Response On Warning
  - 10.4.22 Mar 07, 2007: BSD Medical Comments On FDA Warning Letter Regarding Clinical Study
  - 10.4.23 Feb 26, 2007: Clinical Evidence And Advanced Technology Supporting Hyperthermia Therapy Emphasized At Annual ACRO Conference
  - 10.4.24 Feb 07, 2007: BSD Medical's New Cancer Ablation System Unveiled
  - 10.4.25 Jan 23, 2007: BSD Medical Presents Hyperthermia Cancer Treatment Study At Head And Neck Cancer Symposium
- 10.5 Clinical Trials
  - 10.5.1 May 28, 2008: Phase III Clinical Study Using BSD Medical's Systems For Treating Pancreatic Cancer To Be Announced At ASCO
  - 10.5.2 Oct 17, 2007: Hyperthermia Combined With Radiation And Androgen Therapy Provides Positive Results With Reduced Toxicity For Prostate Cancer Treatments
  - 10.5.3 Sep 27, 2007: BSD Medical Reports Upcoming Publication Of 12-Year Cancer Survival Data Following Landmark Study Of Hyperthermia Therapy
  - 10.5.4 Jun 22, 2007: Twelve-Year Survival Data Shows Durability Of Hyperthermia Therapys Enhancement Of Radiation In Treating Cancer
  - 10.5.5 Jun 05, 2007: Major Study Of BSD Medicals Cancer Therapy In Combination With Chemotherapy Highlighted In ASCO News And In Summary Session
  - 10.5.6 Jun 04, 2007: Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared To Chemotherapy Alone For Sarcoma Cancer Patients
  - 10.5.7 Feb 26, 2007: Clinical Evidence And Advanced Technology Supporting Hyperthermia Therapy Emphasized At Annual ACRO Conference
  - 10.5.8 Jan 23, 2007: BSD Medical Presents Hyperthermia Cancer Treatment Study At Head And Neck Cancer Symposium
- 10.6 Other Significant Developments
  - 10.6.1 Jan 04, 2006: BSD Medical Enters Distribution Agreement With Ktec
11 BSD Medical Corporation Pipeline Products
- 11.1 BSD Medical Corporation Product Pipeline Analysis
  - 11.1.1 BSD Medical Corporation Pipeline Products By Equipment Type
  - 11.1.2 BSD Medical Corporation Pipeline Products By Development Stage
  - 11.1.3 BSD Medical Corporation Pipeline Products By Therapy Area
  - 11.1.4 BSD Medical Corporation Pipeline Products By News Summary
- 11.2 BSD-2000 Hyperthermia System
  - 11.2.1 Product Description
  - 11.2.2 Product Status
  - 11.2.3 Product Milestone
- 11.3 MicroThermX 100 microwave thermal ablation system
  - 11.3.1 Product Description
  - 11.3.2 Product Status
  - 11.3.3 Product Milestone
- 11.4 BSD 2000/3D
  - 11.4.1 Product Description
  - 11.4.2 Product Status
  - 11.4.3 Product Milestone
- 11.5 BSD-2000 3D/MR
  - 11.5.1 Product Description
  - 11.5.2 Product Status
  - 11.5.3 Product Milestone
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
1 List of Tables
- Table 1: BSD Medical Corporation,Key Facts
- Table 2: BSD Medical Corporation, Key Employees,
- Table 3: BSD Medical Corporation, Other Locations
- Table 4: BSD Medical Corporation Pipeline Products by Equipment Type
- Table 5: BSD Medical Corporation Pipeline Products By Development Stage
- Table 6: BSD Medical Corporation Pipeline Products By Therapy Area
- Table 7: BSD Medical Corporation Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: BSD Medical Corporation Pipeline Products By Development Stage
- Figure 2: BSD Medical Corporation Pipeline Products By News Summary
- Figure 3: Global Markets Direct Methodology